Joy Davis - Concepedia

Author

Joy Davis

Also Known As

J Davis, J. Davis, J. R. Davis, Joy Davis

Publications

652

Citations

H-Index

Concepts

All Affiliations

Joy Davis is an author at University of Alberta specializing in medicine, pharmacology, and pharmacotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	52
2	Social Sciences	1	1	14
3	Anesthesia	1	1	14
4	Cell Biology	1	1	38
5	Immunology	1	1	38

Joy Davis

Publications

631

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice Juliet Emamaullee, Joy Davis, Shaheed Merani, Diabetes	2009	377
Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture Christian Toso, Michael McCall, Juliet Emamaullee, Transplant International	2009	78
The Caspase Selective Inhibitor EP1013 Augments Human Islet Graft Function and Longevity in Marginal Mass Islet Transplantation in Mice Juliet Emamaullee, Joy Davis, Rena Pawlick, Diabetes	2008	65
Porcine Marginal Mass Islet Autografts Resist Metabolic Failure Over Time and Are Enhanced by Early Treatment with Liraglutide Juliet Emamaullee, Shaheed Merani, Christian Toso, Endocrinology	2009	38
The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice Michael McCall, Christian Toso, Juliet Emamaullee, Surgery InflammationIslet TransplantationMarginal Mass EngraftmentTransplantationMedicine	2011	38
Caspase Inhibitor Therapy Synergizes With Costimulation Blockade to Promote Indefinite Islet Allograft Survival Juliet Emamaullee, Joy Davis, Rena Pawlick, Diabetes	2010	21
Effects of 4-aminopyridine on rate-related depression of cardiac action potentials Robert F. Gilmour, Joseph J. Salata, Joy Davis American Journal of Physiology-Heart and Circulatory Physiology Cardiac MusclePsychopharmacologyPharmacotherapyExperimental PharmacologyAction Potential Amplitude	1986	14

Page 1